Dr. Sheth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiology-Diagnostic, 2010 - 2014
UPMC Medical EducationInternship, Internal Medicine, 2009 - 2010
Harvard Medical SchoolClass of 2009
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2024 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
American Board of Radiology Interventional Radiology and Diagnostic Radiology- Join now to see all
Publications & Presentations
PubMed
- The Academic Impact of Society of Interventional Radiology Foundation Grants: Report from the Society of Interventional Radiology Foundation/National Institutes of Hea...Koustav Pal, Clifford R Weiss, Terence P F Gade, Emily Glasgow, Kiranpreet Gill
Journal of Vascular and Interventional Radiology. 2025-04-01 - 2 citationsClinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients.Justin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, Zita D Lim, Priya Rao
European Urology Oncology. 2025-04-01 - CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation.Sandra L Grimm, Menuka Karki, Kyle A Blum, Jean-Philippe Bertocchio, Rong He
Clinical Cancer Research. 2025-03-17
Press Mentions
Nanobiotix Announces First Data from the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients with Locally Advanced NSCLCMarch 27th, 2025- TriSalus Life Sciences Expands Clinical Executive Team and Scientific Advisors in Support of Company’s Focus to Overcome Liver and Pancreatic Cancer Treatment Barriers and Enable More Patients to Benefit from ImmunotherapyFebruary 10th, 2022
- How Interventional Radiology Is Used to Manage Cancer-Related Bone PainJanuary 4th, 2022
Grant Support
- An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinomaUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
- Novel Biomarkers Predicting Blood Clots in Ovarian CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
- Novel Biomarkers Predicting Blood Clots in Ovarian CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
